Pfizer Recalls Blood Pressure Drug Accuretic Due To Potential Carcinogen

Mealey's (April 15, 2022, 10:09 AM EDT) -- NEW YORK — Pfizer Inc. on March 21 voluntarily recalled certain lots of its blood pressure drug Accuretic (quinapril) and two authorized generic versions due to the presence of potentially cancer-causing...
To view the full article, register now.